Biblio Discovery — Demo Discovery Service

24 results for "Perry M. Elliott"

Showing 1–20 · 0.90 seconds · RSS

  1. Journal Article

    Arrhythmogenic Cardiomyopathy: A Disease or Merely a Phenotype?

    Alexandros Protonotarios; Perry M Elliott

    European Cardiology Review, Vol. 15 · 2020 · English · DOAJ Scopus

    Arrhythmogenic cardiomyopathy (AC) is a clinical entity that has evolved conceptually over the past 30 years. Advances in cardiac imaging and the introduction of genetics into everyday practice have revealed that AC comprises multiple phenotypes that are dependent on genetic or acquired factors. In…

  2. Journal Article

    ESC National Societies Cardiovascular Journals Editors' Network Almanac 2014: cardiomyopathies

    Oliver P. Guttmann; Saidi A. Mohiddin; Perry M. Elliott

    Türk Kardiyoloji Derneği Arşivi, Vol. 43 No. 3 · 2015 · Turkish · DOAJ Scopus

    Cardiomyopathies are myocardial disorders that are not explained by abnormal loading conditions and coronary artery disease. They are classified into a number of morphological and functional phenotypes that can be caused by genetic and non-genetic mechanisms. The dominant themes in papers published…

  3. Journal Article

    Prevalence of transthyretin cardiac amyloidosis in patients with high-degree AV block

    Petros Syrris; Alexandros Protonotarios; Perry M Elliott et al.

    Open Heart, Vol. 11 No. 1 · 2024 · English · DOAJ Scopus

    Objective Transthyretin amyloid cardiomyopathy (ATTR-CM) is an infiltrative cardiac disorder caused by deposition of wild type or mutated transthyretin. As ATTR-CM is associated with conduction disease, we sought to determine its prevalence in patients with idiopathic high-degree atrioventricular…

  4. Journal Article Full text

    A Proof of Principle 2D Spatial Proteome Mapping Analysis Reveals Distinct Regional Differences in the Cardiac Proteome

    Wendy E. Heywood; Jon Searle; Richard Collis et al.

    Life, Vol. 14 No. 8 · 2024 · English · DOAJ Scopus

    Proteomics studies often explore phenotypic differences between whole organs and systems. Within the heart, more subtle variation exists. To date, differences in the underlying proteome are only described between whole cardiac chambers. This study, using the bovine heart as a model, investigates…

  5. Journal Article

    Cardiac magnetic resonance markers of pre-clinical hypertrophic and dilated cardiomyopathy in genetic variant carriers

    Philip M. Croon; Marion van Vugt; Cornelis P. Allaart et al.

    BMC Medicine, Vol. 23 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Background Patients with hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) exhibit structural and functional cardiac abnormalities. We aimed to identify imaging biomarkers for pre-clinical cardiomyopathy in healthy participants carrying cardiomyopathy-associated variants…

  6. Journal Article

    Patient-derived induced pluripotent stem cells to study non-canonical splicing variants associated with Hypertrophic Cardiomyopathy

    Joanna Jager; Marta Ribeiro; Marta Furtado et al.

    Stem Cell Research, Vol. 81 · 2024 · English · DOAJ Scopus

    Hypertrophic cardiomyopathy (HCM) is the most prevalent inherited cardiomyopathy and a leading cause of sudden death. Genetic testing and familial cascade screening play a pivotal role in the clinical management of HCM patients. However, conventional genetic tests primarily focus on the detection…

  7. Journal Article

    Hypertrophic cardiomyopathy and atrial fibrillation: the Cardiomyopathy/Myocarditis Registry of the EURObservational Research Programme of the European Society of Cardiology

    Juan Pablo Kaski; Cécile Laroche; Perry M Elliott et al.

    Open Heart, Vol. 12 No. 1 · 2025 · English · DOAJ Scopus

    Background Hypertrophic cardiomyopathy (HCM) is commonly associated with atrial fibrillation (AF), but its impact on outcomes in real-world practice is uncertain. The aim of the study was to evaluate the clinical profile and prognosis of patients with HCM and AF.Methods Overall, 1739 adult patients…

  8. Journal Article Full text

    Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors

    Maarten Arends; Marieke Biegstraaten; Derralynn A. Hughes et al.

    PLOS ONE, Vol. 12 No. 8 · 2017 · English · PLOS Scopus

    Despite enzyme replacement therapy, disease progression is observed in patients with Fabry disease. Identification of factors that predict disease progression is needed to refine guidelines on initiation and cessation of enzyme replacement therapy. To study the association of potential biochemical…

    Also available at: DOAJ

  9. Journal Article

    Genetic basis of right and left ventricular heart shape

    Richard Burns; William J. Young; Nay Aung et al.

    Nature Communications, Vol. 15 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Heart shape captures variation in cardiac structure beyond traditional phenotypes of mass and volume. Although observational studies have demonstrated associations with cardiometabolic risk factors and diseases, its genetic basis is less understood. We utilised cardiovascular magnetic…

  10. Journal Article

    Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers

    Rebecca K. Hughes; Claudia Camaioni; João B. Augusto et al.

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 10 No. 15 · 2021 · English · DOAJ Scopus

    Background Impaired myocardial blood flow (MBF) in the absence of epicardial coronary disease is a feature of hypertrophic cardiomyopathy (HCM). Although most evident in hypertrophied or scarred segments, reduced MBF can occur in apparently normal segments. We hypothesized that impaired MBF and…

  11. Journal Article

    The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts

    Dominique P. Germain; Perry M. Elliott; Bruno Falissard et al.

    Molecular Genetics and Metabolism Reports, Vol. 19 · 2019 · English · DOAJ Scopus

    Background: Enzyme replacement therapy (ERT) with recombinant human α-galactosidase has been available for the treatment of Fabry disease since 2001 in Europe and 2003 in the USA. Treatment outcomes with ERT are dependent on baseline patient characteristics, and published data are derived from…

  12. Journal Article

    2018 ESC Guidelines for the diagnosis and management of syncope

    Michele Brignole; Angel Moya; Frederik J. de Lange et al.

    Российский кардиологический журнал, Vol. 0 No. 7 · 2019 · Russian · DOAJ Scopus

    The Task Force for the diagnosis and management of syncope of the European Society of Cardiology (ESC)Developed with the special contribution of the European Heart Rhythm Association (EHRA)Endorsed by: European Academy of Neurology (EAN), European Federation of Autonomic Societies (EFAS), European…

  13. Journal Article

    Identification, clinical manifestation and structural mechanisms of mutations in AMPK associated cardiac glycogen storage disease

    Dan Hu; Dong Hu; Liwen Liu et al.

    EBioMedicine, Vol. 54 · 2020 · English · DOAJ Scopus

    Background: Although 21 causative mutations have been associated with PRKAG2 syndrome, our understanding of the syndrome remains incomplete. The aim of this project is to further investigate its unique genetic background, clinical manifestations, and underlying structural changes. Methods: We…

  14. Journal Article Full text

    No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy

    Edgar T. Hoorntje; Anna Posafalvi; Petros Syrris et al.

    PLOS ONE, Vol. 13 No. 8 · 2018 · English · PLOS Scopus

    Aims: Likely pathogenic/pathogenic variants in genes encoding desmosomal proteins play an important role in the pathophysiology of arrhythmogenic right ventricular cardiomyopathy (ARVC). However, for a substantial proportion of ARVC patients, the genetic substrate remains unknown. We hypothesized…

  15. Journal Article

    Integrin α7 Mutations Are Associated With Adult‐Onset Cardiac Dysfunction in Humans and Mice

    Enrico Bugiardini; Andreia M. Nunes; Ariany Oliveira‐Santos et al.

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 11 No. 23 · 2022 · English · DOAJ Scopus

    Background Integrin α7β1 is a major laminin receptor in skeletal and cardiac muscle. In skeletal muscle, integrin α7β1 plays an important role during muscle development and has been described as an important modifier of skeletal muscle diseases. The integrin α7β1 is also highly expressed in the…